Trinity Biotech (TRIB) EBT Margin Growth (1y) (2010 - 2024)

Trinity Biotech (TRIB) EBT Margin Growth (1y) (2010 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Abbott Laboratories 181.32 Bn 174.03 Bn 6.27 Bn -419.00
2 Stryker 128.59 Bn 125.71 Bn 3.81 Bn 110.00
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 458.00
4 Boston Scientific 67.77 Bn 66.32 Bn 3.61 Bn 507.00
5 Edwards Lifesciences 48.13 Bn 44.46 Bn 1.29 Bn -287.00
6 GE HealthCare Technologies 28.44 Bn 26.15 Bn 1.98 Bn -464.00
7 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn 772.00
8 Smith & Nephew 26.77 Bn 26.20 Bn - -
9 Koninklijke Philips 25.24 Bn 22.11 Bn 2.07 Bn 233.00
10 Trinity Biotech 105.39 Mn 100.25 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -5,863.00
Sep 30, 2024 1,263.00
Jun 30, 2024 9,045.00
Mar 31, 2024 2,049.00
Dec 31, 2023 2,532.00
Sep 30, 2023 1,932.00
Jun 30, 2023 -6,809.00
Mar 31, 2023 4,175.00
Dec 31, 2022 -5,389.00
Sep 30, 2022 -7,086.00
Jun 30, 2022 -6,535.00
Mar 31, 2022 -10,110.00
Dec 31, 2021 3,115.00
Sep 30, 2021 -1,732.00
Jun 30, 2021 -1,125.00
Mar 31, 2021 280.00
Dec 31, 2020 9,961.00
Sep 30, 2020 2,373.00
Jun 30, 2020 1,031.00
Mar 31, 2020 1,297.00